These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1328073)

  • 1. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
    Derbyshire EJ; Wawrzynczak EJ
    Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
    Derbyshire EJ; Wawrzynczak EJ
    Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
    Derbyshire EJ; de Leij L; Wawrzynczak EJ
    Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
    Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
    Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
    Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
    Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
    Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
    Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
    Epstein C; Lynch T; Shefner J; Wen P; Maxted D; Braman V; Ariniello P; Coral F; Ritz J
    Int J Cancer Suppl; 1994; 8():57-9. PubMed ID: 7515030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles.
    Singh M; Griffin T; Salimi A; Micetich RG; Atwal H
    Cancer Lett; 1994 Aug; 84(1):15-21. PubMed ID: 8076359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
    Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
    J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells.
    Wargalla UC; Reisfeld RA
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5146-50. PubMed ID: 2544891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus.
    Wawrzynczak EJ; Henry RV; Cumber AJ; Parnell GD; Derbyshire EJ; Ulbrich N
    Eur J Biochem; 1991 Feb; 196(1):203-9. PubMed ID: 2001699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW; Pagnini PG; Houston LL
    J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.